Yahoo
NasdaqCM - Delayed Quote USD

Waldencast plc (WALD)

0.8794 0.0000 (0.00%)
At close: October 14 at 4:00:00 PM EDT
Ticker Change
WALD is trading under new symbol MLKMF effective Oct. 8, 2026
Chart Range Bar
Loading chart for WALD
  • Previous Close 0.8794
  • Open 0.9600
  • Bid 0.6597 x 200
  • Ask 1.1500 x 200
  • Day's Range 0.8794 - 0.8794
  • 52 Week Range 0.7100 - 3.2200
  • Volume 277,019
  • Avg. Volume 299,958
  • Market Cap (intraday) 111.865M
  • Beta (5Y Monthly) 0.01
  • PE Ratio (TTM) --
  • EPS (TTM) -1.2500
  • Earnings Date Sep 28, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 2.05

Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; cosmetics; and other beauty products. In addition, the company provides foundation, concealer, primer, blush, setting spray, and bronzer categories, as well as sells liner, eyeshadow, and lip color products. It serves distributors, retailers, physicians, and directly to consumers through its e-commerce platforms, and third-party logistics and delivery providers. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.

www.waldencast.com

367

Full Time Employees

December 31

Fiscal Year Ends

Performance Overview

Trailing total returns as of 10/15/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

WALD
0.00%
S&P 500 (^GSPC)
13.13%

1-Year Return

WALD
0.00%
S&P 500 (^GSPC)
16.08%

3-Year Return

WALD
0.00%
S&P 500 (^GSPC)
78.94%

5-Year Return

WALD
0.00%
S&P 500 (^GSPC)
73.19%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY25
Revenue 72.01M
Earnings -33.51M
Profit Margin -46.53%

Q4

FY24

Q1

FY25

Q2

FY25

Q4

FY25

-150M
-100M
-50M
0
50M
-200.0%
-150.0%
-100.0%
-50.0%

Analyst Insights

View More

Analyst Price Targets

1.60
2.05 Average
0.8794 Current
2.50 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 6/2/2026
Analyst Canaccord Genuity
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 2 -> 3

Statistics

View More

Valuation Measures

Annual
As of 9/23/2026
  • Market Cap

    132.75M

  • Enterprise Value

    251.38M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.43

  • Price/Book (mrq)

    0.29

  • Enterprise Value/Revenue

    0.92

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -70.22%

  • Return on Assets (ttm)

    -7.49%

  • Return on Equity (ttm)

    -62.67%

  • Revenue (ttm)

    237.32M

  • Net Income Avi to Common (ttm)

    -274.4M

  • Diluted EPS (ttm)

    -1.2500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.82M

  • Total Debt/Equity (mrq)

    38.16%

  • Levered Free Cash Flow (ttm)

    -237.69M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

0.8794 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: